Glomerulonephritis
📧 Sign up to get email alerts when something new happens for Glomerulonephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency [Phase 4]
A Phase 4 clinical trial evaluating leflunomide plus low-dose corticosteroid in IgA nephropathy with renal insufficiency.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis [Phase 4]
Phase 4 trial comparing mycophenolate mofetil with tacrolimus versus tacrolimus alone for idiopathic membranous glomerulonephritis; complete…
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy [Phase 3]
A phase 3 trial comparing rituximab to steroids and cyclophosphamide for idiopathic membranous nephropathy is being conducted, with status n…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Efficacy and Safety of Losartan in Children With Ig A Nephropathy [Phase 3]
Phase 3 trial update evaluating efficacy and safety of losartan in children with IgA nephropathy (IgA glomerulonephritis) completed.
-
CLINICAL_TRIALS research · 2018-03-09Clinical Trial Update: The Canadian Glomerulonephritis Registry and Translational Research Initiative
This entry describes the Canadian Glomerulonephritis Registry and Translational Research Initiative, a clinical trial sponsored by Universit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 dose-escalation study evaluating long-acting ACTH gel in membranous nephrop…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Recurrent Glomerulonephritis After Renal Transplantation
A completed clinical trial examining recurrent glomerulonephritis after renal transplantation is reported, with Istanbul University listed a…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Shenyankangfu Tablets for primary glomerulonephritis.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) [Phase 2]
A Phase II trial of TRK-100STP for chronic kidney disease due to primary glomerular disease or nephrosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes. [Phase 2]
Phase 2 clinical trial evaluating steroid therapy for IgA nephropathy with active pathological changes; current status is not provided.
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis [Phase 3]
This Phase 3 trial comparing mycophenolate mofetil to tacrolimus for membranous lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy [Phase 4]
A Phase 4 clinical trial assessed probucol in combination with valsartan for IgA nephropathy, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis [Phase 3]
The Phase 3 trial of pentoxifylline for rapidly progressive glomerulonephritis was terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy [Phase 4]
Phase 4 prospective clinical trial evaluating whether aliskiren can protect kidney function in hypertensive patients with IgA nephropathy.
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Calcitriol in the Treatment of Immunoglobulin A Nephropathy [Phase 4]
Phase 4 study of calcitriol for immunoglobulin A nephropathy is reported, with the trial status currently UNKNOWN. Sponsor: Peking Universit…
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor [Phase 3]
Phase 3 trial update evaluating an angiotensin-converting enzyme inhibitor for treating IgA nephropathy, a form of glomerulonephritis.
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy [Phase 2]
A Phase 2 study of olmesartan medoxomil (CS-866) in patients with chronic glomerulonephritis or diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy [NA]
A completed clinical trial assessed whether eradicating Helicobacter pylori reduces proteinuria in patients with membranous nephropathy, nep…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Lamivudine for Chronic Hepatitis B [Phase 2]
This update reports the completion of a Phase 2 trial evaluating lamivudine for chronic hepatitis B. The study also involved related conditi…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Cyclophosphamide and Fludarabine to Treat Lupus Nephritis [Phase 1]
A Phase 1 trial evaluating cyclophosphamide and fludarabine for lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 clinical trial evaluating once-a-month steroid treatment for focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2006-06-27Clinical Trial Update: Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis [Phase 1]
Phase 1 trial assessing the effects of systemic nitric oxide inhibition on renal hemodynamics in people with autosomal dominant polycystic k…